Request Trial

Pharma news

Reset all filters
Geography
Company
Refine search
What makes a life sciences deal stack up for buyers?
Regulation & Industry
What makes a life sciences deal stack up for buyers?
While promising science draws in buyers, intellectual property determines the price, terms, and viability of an agreement. LSIPR digs into what buyers are looking for—and the biggest turn-offs that destroy a deal.   25 August 2026
Stris & Maher opens new Dallas office with partner hires
Careers
Stris & Maher opens new Dallas office with partner hires
The four-person team adds significant life sciences experience to the litigation boutique, drawn to move firms by Stris’ “outstanding trial lawyers” and “sophisticated appellate capabilities”.   24 August 2026
Teva and Aurinia settle generics dispute over lupus drug, voclosporin
Pharma
Teva and Aurinia settle generics dispute over lupus drug, voclosporin
Under the terms of the agreement, which resolves all patent litigation between the biopharma rivals, Teva now has a launch date for its own version of Aurinia's Lupkynis.   21 August 2026
Pharma
SK Biopharmaceuticals settles epilepsy generic dispute
A reported deal with an Indian manufacturer could clear a path for a future generic launch as the Korean drugmaker leverages one of its biggest US products.   20 August 2026
Pharma
Vanda revives challenge over braille-free label on generic sleep disorder drug
Questions over braille on a generic sleep disorder drug label will face fresh scrutiny after an appeals court found fault with the FDA’s approach.   19 August 2026
Biotech
Europe’s missing biotech bridge: Why IP ownership matters more than capital access
Europe’s biotechnology challenge is not only whether it can fund innovation. It is whether it can continue to originate and control the foundational IP positions from which future biotech value is created. Paul Calvo of Sterne Kessler explains.   17 August 2026
Pharma
Novartis scores UK win in high-stakes Entresto fight
Pressure for generic manufacturers of the blockbuster heart drug Entresto is mounting as the Swiss pharma company secures a win over a challenge to its UK patent protection.   14 August 2026
Pharma
The ‘Triple Point’ professional: Why patent success requires science, law, and technology
Reflecting on decades of patent searching experience, senior scientist on the CAS IP Services team, David Saari, offers insights into the importance of a multidisciplinary approach in today's competitive IP landscape.   12 August 2026
Pharma
Lilly mounts defence as generics circle Mounjaro and Zepbound
A litigation campaign against generic drugmakers, including Sandoz, Hikma, and Amenal, raise the stakes in the fight over two of the world’s most lucrative weight loss and diabetes treatments.   11 August 2026
Pharma
Reading Stief, Haedicke and Wünsche, with the memory of a decade fought in Germany
Takanori Abe of Abe & Partners brings the perspective of a lawyer with first-hand experience in the German courtrooms to Pharmaceutical, Biological and Chemical Patents, a valuable resource on case law.   10 August 2026